Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma by Hollis, Robert L., Thomson, John P., van Baal, Juliette, Ilenkovan, Narthana, Churchman, Michael, van de Vijver, Koen, Dijk, Frederike, Meynert, Alison M., Bartos, Clare, Rye, Tzyvia, Croy, Ian, Diana, Patricia, van Gent, Mignon, Creedon, Helen, Nirsimloo, Rachel, Lok, Christianne, Gourley, Charlie, Herrington, C. Simon

Get full text

Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome by Thomson, John P., Hollis, Robert L., van Baal, Juliette, Ilenkovan, Narthana, Churchman, Michael, van de Vijver, Koen, Dijk, Frederike, Meynert, Alison M., Bartos, Clare, Rye, Tzyvia, Croy, Ian, Diana, Patricia, van Gent, Mignon, Creedon, Helen, Nirsimloo, Rachel, Nussey, Fiona, Lok, Christianne, Herrington, C. Simon, Gourley, Charlie

Get full text

High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma by Hollis, Robert L., Elliott, Richard, Dawson, John C., Ilenkovan, Narthana, Matthews, Rosie M., Stillie, Lorna J., Oswald, Ailsa J., Kim, Hannah, Llaurado Fernandez, Marta, Churchman, Michael, Porter, Joanna M., Roxburgh, Patricia, Unciti-Broceta, Asier, Gershenson, David M., Herrington, C. Simon, Carey, Mark S., Carragher, Neil O., Gourley, Charlie

Get full text